Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. It is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida. more
Time Frame | SILO | Sector | S&P500 |
---|---|---|---|
1-Week Return | 13.92% | 2.44% | 2.58% |
1-Month Return | 8.09% | -4.49% | 0.09% |
3-Month Return | -10.26% | -8.82% | 4.76% |
6-Month Return | -5.82% | -4.46% | 9.89% |
1-Year Return | -40.18% | 3.16% | 26.47% |
3-Year Return | -86.21% | -0.83% | 25.98% |
5-Year Return | 157.08% | 35.65% | 86.34% |
10-Year Return | -52.44% | 101.94% | 189.21% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 40.57K | 40.92K | 71.26K | 72.10K | 72.10K | [{"date":"2019-12-31","value":56.27,"profit":true},{"date":"2020-12-31","value":56.76,"profit":true},{"date":"2021-12-31","value":98.84,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 27.39K | 176.13K | 5.00K | 5.84K | 877.46K | [{"date":"2019-12-31","value":3.12,"profit":true},{"date":"2020-12-31","value":20.07,"profit":true},{"date":"2021-12-31","value":0.57,"profit":true},{"date":"2022-12-31","value":0.67,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 13.18K | (135.20K) | 66.26K | 66.26K | (805.36K) | [{"date":"2019-12-31","value":19.89,"profit":true},{"date":"2020-12-31","value":-204.04,"profit":false},{"date":"2021-12-31","value":99.99,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-1215.38,"profit":false}] |
Gross Margin | 32.49% | (330.38%) | 92.98% | 91.90% | (1116.97%) | [{"date":"2019-12-31","value":34.95,"profit":true},{"date":"2020-12-31","value":-355.33,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.84,"profit":true},{"date":"2023-12-31","value":-1201.33,"profit":false}] |
Operating Expenses | 927.64K | 2.27M | 2.96M | 3.71M | 3.05M | [{"date":"2019-12-31","value":24.98,"profit":true},{"date":"2020-12-31","value":61.19,"profit":true},{"date":"2021-12-31","value":79.68,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.13,"profit":true}] |
Operating Income | (930.40K) | (2.57M) | (2.74M) | (3.65M) | (3.86M) | [{"date":"2019-12-31","value":-93040300,"profit":false},{"date":"2020-12-31","value":-257296700,"profit":false},{"date":"2021-12-31","value":-274434300,"profit":false},{"date":"2022-12-31","value":-364765600,"profit":false},{"date":"2023-12-31","value":-385560000,"profit":false}] |
Total Non-Operating Income/Expense | (133.62K) | (722.27K) | 6.92M | (189.29K) | 578.74K | [{"date":"2019-12-31","value":-1.93,"profit":false},{"date":"2020-12-31","value":-10.43,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2.73,"profit":false},{"date":"2023-12-31","value":8.36,"profit":true}] |
Pre-Tax Income | (1.01M) | (3.04M) | 4.18M | (3.91M) | (3.63M) | [{"date":"2019-12-31","value":-24.23,"profit":false},{"date":"2020-12-31","value":-72.63,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-93.43,"profit":false},{"date":"2023-12-31","value":-86.83,"profit":false}] |
Income Taxes | 34.79K | 92.35K | 24.88K | 1.16K | 69.60K | [{"date":"2019-12-31","value":37.67,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":26.94,"profit":true},{"date":"2022-12-31","value":1.26,"profit":true},{"date":"2023-12-31","value":75.37,"profit":true}] |
Income After Taxes | (1.05M) | (3.13M) | 4.16M | (3.91M) | (3.70M) | [{"date":"2019-12-31","value":-25.21,"profit":false},{"date":"2020-12-31","value":-75.29,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-94.02,"profit":false},{"date":"2023-12-31","value":-89.02,"profit":false}] |
Income From Continuous Operations | (1.01M) | (3.04M) | 4.16M | (3.91M) | (4.24M) | [{"date":"2019-12-31","value":-24.37,"profit":false},{"date":"2020-12-31","value":-73.07,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-93.99,"profit":false},{"date":"2023-12-31","value":-102.05,"profit":false}] |
Income From Discontinued Operations | (371.25K) | (371.25K) | (253.37K) | - | - | [{"date":"2019-12-31","value":-37124800,"profit":false},{"date":"2020-12-31","value":-37124800,"profit":false},{"date":"2021-12-31","value":-25336700,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (1.05M) | (3.13M) | 3.90M | (3.91M) | (3.70M) | [{"date":"2019-12-31","value":-26.85,"profit":false},{"date":"2020-12-31","value":-80.18,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-100.12,"profit":false},{"date":"2023-12-31","value":-94.8,"profit":false}] |
EPS (Diluted) | (0.05) | (0.09) | 2.80 | (1.65) | (1.18) | [{"date":"2019-12-31","value":-1.71,"profit":false},{"date":"2020-12-31","value":-3.11,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-59.01,"profit":false},{"date":"2023-12-31","value":-42.33,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
SILO | |
---|---|
Current Ratio | 5.84 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
SILO | |
---|---|
ROA (LTM) | -26.11% |
ROE (LTM) | -48.34% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
SILO | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.26 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.74 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
SILO | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 59.62 |
P/B | 0.63 |
Price/FCF | NM |
EV/R | 9.71 |
EV/Ebitda | 0.56 |
Silo Pharma Inc (SILO) share price today is $0.9512
Yes, Indians can buy shares of Silo Pharma Inc (SILO) on Vested. To buy Silo Pharma Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SILO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Silo Pharma Inc (SILO) via the Vested app. You can start investing in Silo Pharma Inc (SILO) with a minimum investment of $1.
You can invest in shares of Silo Pharma Inc (SILO) via Vested in three simple steps:
The 52-week high price of Silo Pharma Inc (SILO) is $4.5. The 52-week low price of Silo Pharma Inc (SILO) is $0.77.
The price-to-earnings (P/E) ratio of Silo Pharma Inc (SILO) is
The price-to-book (P/B) ratio of Silo Pharma Inc (SILO) is 0.63
The dividend yield of Silo Pharma Inc (SILO) is 0.00%
The market capitalization of Silo Pharma Inc (SILO) is $4.30M
The stock symbol (or ticker) of Silo Pharma Inc is SILO